Ultrasound-guided paraspinatus block used as a treatment for segmental spinal sensitization.

Authors

  • Ariel Marcelo Finkelsteyn Sanatorio de la Providencia y Centro Fintea. Buenos Aires. Argentina.

DOI:

https://doi.org/10.47924/neurotarget202069

Keywords:

segmental spinal sensitization

Abstract

Spinal segmental sensitization syndrome (SSS) is a chronic regional musculoskeletal pain syndrome first described by Dr. Andrew A. Fischer in 1997, based on the work of Dr. C. Chan Gunn and Dr. Robert Maigne. This syndrome is very common in everyday physiatric consultation. Around 30% of patients who consult a rehabilitation clinic for chronic pain had SES.

Metrics

Metrics Loading ...

References

Imamura M, Imamura ST, Targino RA,Morales-Quezada L, Onoda Tomikawa LC, Onoda Tomikawa LG, Alfieri FM, Filippo TR, da Rocha ID, Neto RB, Fregni F, Battistella LR. Paraspinous Lidocaine Injection for Chronic Nonspecific Low Back Pain: A Randomized Controlled Clinical Trial. J Pain. 2016; 17(5):569-76. doi: 10.1016/j.jpain.2016.01.469. Epub 2016 Jan 30. PMID: 26828801; PMCID: PMC4910884.

Nakazato NT, Romero VP. El síndrome de sensibilización espinal segmentaria: nueva propuesta de criterios diagnósticos para la investigación. Rev Mex Med Fis Rehab. 2019; 31(1-2):6-12.

Published

2020-04-01

How to Cite

1.
Finkelsteyn AM. Ultrasound-guided paraspinatus block used as a treatment for segmental spinal sensitization. NeuroTarget [Internet]. 2020 Apr. 1 [cited 2024 Nov. 21];14(1):13-6. Available from: https://neurotarget.com/index.php/nt/article/view/69

Issue

Section

Short communications